Nike, DJT Rise; Corcept Falls

On this episode of stock movers:

• Nike (NKE) shares rose on Wednesday after CEO Elliott Hill reported the purchase of about $1 million in shares.
• Corcept (CORT) shares fell after US regulators rejected the company’s drug to treat a form of high blood pressure.
• The Food and Drug Administration “could not arrive at a favorable benefit-risk assessment” for the company’s drug, relacorilant, without more evidence of its effectiveness, the Redwood City, California-based company said in a statement Wednesday. 
• Trump Media and Technology Group (DJT) shares rose on news the company, which operates President Donald Trump’s Truth Social platform, plans to issue a new cryptocurrency, which will be distributed among its shareholders.

See omnystudio.com/listener for privacy information.